Warkentin TE - Search Results

1

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Warkentin TE, Pai M, Linkins LA. Warkentin TE, et al. Blood. 2017 Aug 31;130(9):1104-1113. doi: 10.1182/blood-2017-04-778993. Epub 2017 Jun 23. Blood. 2017. PMID: 28646118 Free article. Review.

2

Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.

Kelton JG, Warkentin TE, Hayward CP, Murphy WG, Moore JC. Kelton JG, et al. Among authors: warkentin te. Blood. 1992 Nov 1;80(9):2246-51. Blood. 1992. PMID: 1421394 Free article.

3

Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b).

Warkentin TE, Smith JW, Hayward CP, Ali AM, Kelton JG. Warkentin TE, et al. Blood. 1992 May 1;79(9):2480-4. Blood. 1992. PMID: 1571561 Free article.

4

Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

Demers C, Ginsberg JS, Brill-Edwards P, Panju A, Warkentin TE, Anderson DR, Turner C, Kelton JG. Demers C, et al. Among authors: warkentin te. Blood. 1991 Nov 1;78(9):2194-7. Blood. 1991. PMID: 1932741 Free article.

5

Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG. Warkentin TE, et al. Blood. 1994 Dec 1;84(11):3691-9. Blood. 1994. PMID: 7949124 Free article.

6

Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P. Kelton JG, et al. Among authors: warkentin te. Blood. 1994 Jun 1;83(11):3232-9. Blood. 1994. PMID: 8193358 Free article.

7

Newer strategies for the treatment of heparin-induced thrombocytopenia.

Warkentin TE, Barkin RL. Warkentin TE, et al. Pharmacotherapy. 1999 Feb;19(2):181-95. doi: 10.1592/phco.19.3.181.30928. Pharmacotherapy. 1999. PMID: 10030768 Review.

8

Morphological analysis of microparticle generation in heparin-induced thrombocytopenia.

Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG. Hughes M, et al. Among authors: warkentin te. Blood. 2000 Jul 1;96(1):188-94. Blood. 2000. PMID: 10891450 Free article.

9

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Warkentin TE, et al. Blood. 2000 Sep 1;96(5):1703-8. Blood. 2000. PMID: 10961867 Free article.

10

Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders.

Moore JC, Hayward CP, Warkentin TE, Kelton JG. Moore JC, et al. Among authors: warkentin te. Blood. 2001 Sep 15;98(6):1842-6. doi: 10.1182/blood.v98.6.1842. Blood. 2001. PMID: 11535519 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters